Successful Central Nervous System Prophylaxis Without Radiotherapy in Childhood Acute Lymphoblastic Leukemia (ALL); Israel National Studies (INS 1984, 1989)

[1]  T. Oshima.  [Treatment of acute lymphocytic leukemia]. , 1992, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[2]  A. Look,et al.  Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Farndon,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER , 1987, The Lancet.

[4]  B. Powell,et al.  Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias. , 1987, Seminars in oncology.

[5]  Judith M. Chesseixs,et al.  CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA: THE LATE EFFECTS OF TREATMENT , 1983 .

[6]  P. Dyment,et al.  Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study , 1982 .

[7]  L. Robison,et al.  Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group. , 1982, Cancer research.

[8]  H. Thaler,et al.  A long‐term clinical follow‐up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens , 1980, Cancer.

[9]  A. Mauer.  Therapy of Acute Lymphoblastic Leukemia in Childhood , 1980 .

[10]  D. Green,et al.  COMPARISON OF THREE METHODS OF CENTRAL-NERVOUS-SYSTEM PROPHYLAXIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKÆMIA , 1980, The Lancet.

[11]  D. Pinkel.  The ninth annual david karnofsky lecture. Treatment of acute lymphocytic leukemia , 1979, Cancer.

[12]  G. Henze,et al.  Results and significance of six randomized trials in four consecutive ALL-BFM studies. , 1990, Haematology and blood transfusion.

[13]  C. Pui,et al.  High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study X. , 1988, Medical and pediatric oncology.

[14]  M. Schrappe,et al.  Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis. , 1987, Haematology and blood transfusion.

[15]  R. Riccardi,et al.  Central nervous system leukemia : prevention and treatment , 1983 .

[16]  R. Price.  Therapy Related Central Nervous System Diseases in Children with Acute Lymphocytic Leukemia , 1983 .

[17]  H. Sather,et al.  Prolonged second remissions in childhood acute lymphocytic leukemia: a report from the Childrens Cancer Study Group. , 1983, Medical and pediatric oncology.

[18]  W. Bleyer.  Neurologic sequelae of methotrexate and ionizing radiation: a new classification. , 1981, Cancer treatment reports.